Polycystic liver disease: a clinical review
Open Access
- 1 November 2012
- journal article
- review article
- Published by Elsevier in Annals of Hepatology
- Vol. 11 (6) , 819-826
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Systematic review: the pathophysiology and management of polycystic liver diseaseAlimentary Pharmacology & Therapeutics, 2011
- Medical and Surgical Treatment Options for Polycystic Liver DiseaseHepatology, 2010
- Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63Clinical Genetics, 2010
- PRKCSH/80K-H, the protein mutated in polycystic liver disease, protects polycystin-2/TRPP2 against HERP-mediated degradationHuman Molecular Genetics, 2009
- Autosomal dominant polycystic kidney disease: the last 3 yearsKidney International, 2009
- Advances in management of polycystic liver diseaseExpert Review of Gastroenterology & Hepatology, 2008
- Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver diseaseGastroenterology, 2004
- Mutations in SEC63 cause autosomal dominant polycystic liver diseaseNature Genetics, 2004
- Mutations in PRKCSH Cause Isolated Autosomal Dominant Polycystic Liver DiseaseThe American Journal of Human Genetics, 2003
- Clinical profile of autosomal dominant polycystic liver diseaseHepatology, 2003